His unofficial expectation is that sales will hit $100 million “sometime in December.”
No wonder then, as The Sun recently reported, that several large, national companies are seeking to consolidate licenses to grow, process and sell in Maryland and in states across the nation.
Massachusetts-based Curaleaf, which has its own licenses in Maryland, has offered to buy a competitor’s licenses here for $30 million. The price tag provided one of the first peeks into how companies are valuing the licenses in Maryland.
In regulatory filing in Canada and the United States before going public, Curaleaf reported raising $400 million, including selling $121 million worth of shares to 86 people in 16 U.S. states, including Maryland. Identities are not disclosed in such records but would include savvy, wealthy investors, large banks and other institutions.
Curaleaf’s majority owner, Boris Jordan, told Bloomberg Businessweek last year that his Moscow-based private equity firm, Sputnik Group, had spent $100 million to prepare the company for the expansion that now has it operating in 12 states.
“In the early 1990s, Mr. Jordan was considered a key player in the development of the Russian stock market and was a leader in the privatization of Russian state assets” when the Soviet Union collapsed, according to the company’s website.